ST Engineering
S63
Singtel
Z74
Wilmar Intl
F34
SIA
C6L
Keppel
BN4
SG Stock MarketDetailed Quotes
HQXW IX BiopharmaW260718
- 0.003
- 0.0000.00%
10min DelayMarket Closed Feb 17 16:42 CST
2.65MMarket Cap0.00P/E (TTM)
0.000High0.000Low0Volume0.000Open0.003Pre Close0.00Turnover0.01052wk High0.00%Turnover Ratio883.34MShares0.00152wk Low--EPS TTM1.29MFloat Cap0.010Historical High0.00P/E (Static)430.72MShs Float0.001Historical Low--EPS LYR0.00%Amplitude--Dividend TTM0.00P/B100Lot Size--Div YieldTTM
IX BiopharmaW260718 Key Stats
Quarterly+Annual
YOY
| (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (Q2)Dec 31, 2019 | (Q1)Sep 30, 2019 | (FY)Jun 30, 2019 | (Q4)Jun 30, 2019 | (Q3)Mar 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0.78%5.96M | -58.91%5.91M | 724.64%14.39M | 77.16%1.75M | 46.80%985K | 62.62%174K | 18.81%120K | 172.76%671K | -92.21%129K | 254.26%333K |
| Cost of revenue | 36.68%4.91M | 71.10%3.59M | -1.27%2.1M | 35.31%2.13M | 31.00%1.57M | 125.68%334K | 74.02%355K | 143.41%1.2M | -76.95%343K | 271.85%502K |
| Gross profit | -54.83%1.05M | -81.12%2.32M | 3,317.28%12.29M | 34.92%-382K | -10.96%-587K | -290.24%-160K | -128.16%-235K | -114.17%-529K | -228.14%-214K | -312.20%-169K |
| Operating expense | -26.13%7.93M | -2.89%10.73M | 13.95%11.05M | -7.19%9.7M | -8.24%10.45M | -11.20%2.8M | -10.95%2.72M | -19.83%11.39M | -56.30%2.42M | -17.85%2.76M |
| Selling and administrative expenses | -25.85%6.71M | -4.37%9.04M | 13.94%9.46M | -3.54%8.3M | 9.69%8.61M | 4.69%2.28M | 19.38%2.01M | 6.09%7.85M | -16.14%1.87M | 21.37%2.12M |
| -Selling and marketing expense | -23.13%2.44M | 52.96%3.17M | -7.74%2.08M | -0.44%2.25M | 11.61%2.26M | -9.35%543K | 55.77%648K | 19.69%2.02M | -2.58%566K | 9.93%443K |
| -General and administrative expense | -27.33%4.27M | -20.48%5.87M | 22.00%7.38M | -4.65%6.05M | 9.02%6.35M | 10.03%1.73M | 7.42%1.36M | 2.05%5.82M | -20.94%1.3M | 24.80%1.68M |
| Research and development costs | -38.65%1.73M | 20.93%2.82M | -15.11%2.33M | 9.92%2.75M | -33.63%2.5M | -46.57%522K | -48.04%715K | -53.12%3.77M | -76.48%780K | -60.62%632K |
| Total other operating income | -55.08%509K | 53.32%1.13M | -45.26%739K | 105.79%1.35M | 192.86%656K | ---- | ---- | -81.70%224K | ---- | ---- |
| Operating profit | 18.21%-6.88M | -778.31%-8.41M | 112.30%1.24M | 8.66%-10.08M | 7.39%-11.04M | 7.33%-2.96M | 6.42%-2.96M | 17.54%-11.92M | 50.96%-2.64M | 13.87%-2.93M |
| Net non-operating interest income expense | -54.92%-409K | -30.69%-264K | -20.96%-202K | -10.60%-167K | -297.37%-151K | 6.56%-57K | -3.33%-62K | -40.74%-38K | 310.61%139K | -67.65%-57K |
| Non-operating interest income | 371.43%33K | --7K | --0 | -91.95%7K | -55.15%87K | ---- | ---- | -13.00%194K | ---- | ---- |
| Non-operating interest expense | 63.10%442K | 34.16%271K | 16.09%202K | -26.89%174K | 2.59%238K | -6.56%57K | 3.33%62K | -7.20%232K | -16.67%55K | 67.65%57K |
| Net investment income | 102.74%76K | -45.11%-2.77M | -206.46%-1.91M | 367.45%1.8M | 123.19%384K | -52.63%-1.66M | ||||
| Gain/Loss on financial instruments designated as cash flow hedges | ||||||||||
| Gain/Loss on derecognition of available-for-sale financial assets | -244.14%-2.51M | 153.45%1.74M | -3.26M | 0 | ||||||
| Income from associates and other participating interests | ||||||||||
| Special income /charges | -107K | 0 | ||||||||
| Less:Write off | --107K | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other non-operating income /expenses | -155K | -84.86%33K | -28.05%218K | -11.14%303K | 277.61%595K | -148.09%-325K | 4.60%341K | -38.23%677K | 118.95%130K | |
| Income before tax | -2.87%-9.99M | -136.79%-9.71M | 50.21%-4.1M | 21.58%-8.23M | 20.87%-10.5M | 32.55%-2.42M | 0.21%-3.35M | 12.91%-13.27M | 19.99%-3.48M | 30.71%-2.85M |
| Income tax | 989.01%809K | -118.24%-91K | 49,800.00%499K | 1K | 0 | 0 | 0 | -142.31%-22K | -51.72%14K | 44.12%-19K |
| Net income | -12.26%-10.79M | -109.11%-9.62M | 44.16%-4.6M | 21.57%-8.23M | -251.02%-10.5M | 32.82%-2.42M | -3.21%-3.35M | 80.18%-2.99M | 13.79%-3.77M | 277.27%7.62M |
| Net income continuous operations | -12.26%-10.79M | -109.11%-9.62M | 44.16%-4.6M | 21.57%-8.23M | 20.74%-10.5M | 32.23%-2.42M | 0.21%-3.35M | 13.35%-13.25M | 20.20%-3.49M | 30.60%-2.83M |
| Net income discontinuous operations | ---- | ---- | ---- | ---- | ---- | --0 | --0 | 5,213.47%10.26M | ---280K | 4,917.51%10.45M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -12.26%-10.79M | -109.11%-9.62M | 44.16%-4.6M | 21.57%-8.23M | -251.02%-10.5M | 32.82%-2.42M | -3.21%-3.35M | 80.18%-2.99M | 13.79%-3.77M | 277.27%7.62M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -12.26%-10.79M | -109.11%-9.62M | 44.16%-4.6M | 21.57%-8.23M | -251.02%-10.5M | 32.82%-2.42M | -3.21%-3.35M | 80.18%-2.99M | 13.79%-3.77M | 277.27%7.62M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | ||||||||||
| Diluted earnings per share | ||||||||||
| Dividend per share | ||||||||||
| Currency Unit | SGD | SGD | SGD | SGD | SGD | SGD | SGD | SGD | SGD | SGD |
Trending Stocks
SG High Dividend SG High Dividend
Singapore's high dividend stocks offer a compelling investment opportunity for those seeking to generate regular income while participating in the potential growth of some of the region's most stable companies. By understanding the benefits and challenges associated with these stocks and conducting thorough research before investing, individuals can effectively incorporate high dividend stocks into their investment strategy. Always consider consulting with financial advisors to tailor investments to your personal financial goals and risk tolerance. With the right approach, high dividend stocks can be a valuable addition to a well-rounded investment portfolio. Singapore's high dividend stocks offer a compelling investment opportunity for those seeking to generate regular income while participating in the potential growth of some of the region's most stable companies. By understanding the benefits and challenges associated with these stocks and conducting thorough research before investing, individuals can effectively incorporate high dividend stocks into their investment strategy. Always consider consulting with financial advisors to tailor investments to your personal financial goals and risk tolerance. With the right approach, high dividend stocks can be a valuable addition to a well-rounded investment portfolio.